Theriva Biologics, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for TOVX, updated each market day.
TOVX AI Sentiment
AI predicts Theriva Biologics, Inc. stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Theriva Biologics, Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
Sector
Exchange
Market Cap
$11,803,594
Cap Tier
Employees
16
Headquarters
ROCKVILLE, MD
Listed Since
April 5, 1993
Website
TOVX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
TOVX Volatility
Theriva Biologics, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
